Wyss Institute’s AminoX project receives funding from Northpond Labs to accelerate innovation in protein-based therapeutics
April 08, 2024 11:00 ET
|
Wyss Institute at Harvard University
Boston, MA, April 08, 2024 (GLOBE NEWSWIRE) -- The Wyss Institute for Biologically Inspired Engineering at Harvard University and Northpond Ventures announced today that the VC firm’s affiliate...
Harvard’s Wyss Institute and Collaborative Fund cofound research lab to fund technology to combat climate change
May 23, 2023 09:00 ET
|
Wyss Institute at Harvard University
Boston, MA, May 23, 2023 (GLOBE NEWSWIRE) -- Collaborative Fund and the Wyss Institute for Biologically Inspired Engineering at Harvard University are joining forces to launch a research and...
Wyss Institute’s Lab-on-a-Molecule Drug Discovery Project Receives Funding from Northpond Labs
April 04, 2023 09:00 ET
|
Wyss Institute at Harvard University
Boston, April 04, 2023 (GLOBE NEWSWIRE) -- (BOSTON, INSERT DATE) —The Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston Children’s Hospital, and Northpond Labs, the...
Gameto licenses Wyss Institute’s technology for growing human ovaries from Harvard University
February 21, 2023 08:00 ET
|
Wyss Institute at Harvard University
BOSTON, MA, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Despite the fact that we all start out as an egg cell in one of our mother’s ovaries, these human reproductive organs are surprisingly under-studied....
Wyss Institute at Harvard University partners with Northpond Labs to launch RNA solutions company EnPlusOne Biosciences
December 19, 2022 10:14 ET
|
Wyss Institute at Harvard University
Boston, Dec. 19, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and EnPlusOne Biosciences (EnPlusOne Bio) announced that...
Sherlock Biosciences licenses Wyss Institute’s ambient nucleic acid amplification technology from Harvard to develop highly accurate, low-cost diagnostics for point-of-need
October 17, 2022 11:00 ET
|
Wyss Institute at Harvard University
Boston, Oct. 17, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Sherlock Biosciences Inc., announced that Sherlock has...
Unravel Biosciences licenses Wyss Institute platform technology from Harvard and Tufts University to decode, model, and treat complex diseases
September 27, 2022 13:38 ET
|
Wyss Institute at Harvard University
Boston, MA, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Today, Unravel Biosciences and the Wyss Institute for Biologically Inspired Engineering at Harvard University announced that Unravel has licensed a...
Wyss Institute at Harvard University launches SPEAR Bio to empower disease research, patient care, and drug development with its small-sample, ultrasensitive, protein-detection technology
August 23, 2022 11:45 ET
|
Wyss Institute at Harvard University
Wyss Institute at Harvard University, Aug. 23, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc.announced...
3EO Health licenses Wyss Institute technology from Harvard, aiming to develop at-home molecular testing with PCR-grade sensitivity and antigen test–level cost
August 04, 2022 09:00 ET
|
Wyss Institute at Harvard University
Wyss Institute for Biologically Inspired Engineering at Harvard University, Aug. 04, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard...
Harvard Wyss Institute’s eRapid multiplexed biosensor technology licensed to StataDX to enable new diagnostics for neurological, cardiovascular, and renal diseases
June 27, 2022 09:00 ET
|
Wyss Institute at Harvard University
Wyss Institute for Biologically Inspired Engineering at Havard University, June 27, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today the Wyss Institute for Biologically Inspired Engineering at Harvard...